United States of America ex rel. Dinesh S. Thakur v. Ranbaxy et al. – Key Facts 1. On May 13, 2013, Ranbaxy, India’s largest generic drug manufacturer, agreed to pay $500 million to the United States and thirty-two S - Ex rel - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2013-05-13 12:26:02		United States of America ex rel. Dinesh S. Thakur v. Ranbaxy et al. – Key Facts 1. On May 13, 2013, Ranbaxy, India’s largest generic drug manufacturer, agreed to pay $500 million to the United States and thirty-two S Add to Reading List Source URL: dineshthakur.com Download Document from Source Website File Size: 26,58 KB Share Document on Facebook